Viz AAA vs Viz HCM

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Viz.ai
VS
by Viz.ai

AI Verdict

Viz AAA focuses on the AI-powered detection and triage of suspected Abdominal Aortic Aneurysm from CT angiography scans, primarily aiding radiology and vascular surgery. In contrast, Viz HCM uses AI for real-time ECG analysis to detect Hypertrophic Cardiomyopathy, streamlining cardiac care coordination for cardiology and hospital medicine. While both are FDA-cleared AI solutions from the same vendor that enhance care coordination, they target distinct pathologies and utilize different diagnostic modalities.

Choose Viz AAA if…

Choose Viz AAA if your institution requires rapid, AI-powered detection and triage of suspected Abdominal Aortic Aneurysm (AAA) directly from CT angiography scans. This tool is ideal for emergency departments and vascular surgery teams needing to accelerate diagnosis, facilitate real-time care coordination, and improve patient outcomes for this critical condition.

View Viz AAA →

Choose Viz HCM if…

Choose Viz HCM if your cardiology or emergency department aims to significantly reduce the time to diagnosis for Hypertrophic Cardiomyopathy (HCM) through real-time AI analysis of ECGs. This solution is best suited for streamlining cardiac care coordination, ensuring prompt referral to specialists, and integrating seamlessly into existing clinical workflows for early HCM management.

View Viz HCM →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Viz AAA Viz HCM
Pricing Enterprise (hospital/health system) Unknown
Deployment Cloud-based, integrates with PACS and EHR systems. Unknown
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Viz AAA Viz HCM
Name Viz AAA Viz HCM
Description Viz AAA is the first FDA-cleared AI-powered solution by Viz.ai for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, designed to accelerate diagnosis and care coordination. Viz HCM is an FDA-cleared AI tool by Viz.ai that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time.
Company Viz.ai Viz.ai
Primary Detection Method AI-powered automatic detection of suspected AAA from CTA scans AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection
Key Feature 1 AI-powered automatic detection of suspected AAA from CTA scans AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection
Key Feature 2 Automated triage and prioritization of cases Real-time disease detection from electrocardiograms

Videos

Demos, reviews, and walkthroughs featuring Viz AAA and Viz HCM.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Viz AAA is an AI-powered solution for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans. In contrast, Viz HCM is an AI tool that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM).
Viz AAA is designed for specialties such as Emergency Medicine, Radiology, and Vascular Surgery to accelerate AAA diagnosis and care coordination. Viz HCM targets Cardiology, Emergency Medicine, and Hospital Medicine to streamline cardiac care for HCM.
Both Viz AAA and Viz HCM are cloud-based platforms designed for seamless integration into existing hospital workflows, including EHR and PACS systems. They provide real-time alerts and communication platforms to multidisciplinary care teams.
Viz AAA focuses on accelerating diagnosis and care coordination for AAA through automatic detection, automated triage, and real-time alerts to care teams. Viz HCM aims to significantly reduce diagnosis time for HCM by using AI-powered ECG analysis, mobile alerts, and automated direction of patients to appropriate care specialists.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.